Menicon Co., Ltd. (7780) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Menicon Co., Ltd. (7780:JPX), powered by AI.

Current Price
¥1,641
P/E Ratio
22.2
Market Cap
124.6B
Sector
Healthcare
What is the Menicon Co., Ltd. stock price forecast?

Menicon Co., Ltd. is currently trading at ¥1,641. View real-time AI analysis on Alpha Lenz.

What is Menicon Co., Ltd. insider trading activity?

View the latest insider trading data for Menicon Co., Ltd. on Alpha Lenz.

What is Menicon Co., Ltd.'s P/E ratio?

Menicon Co., Ltd.'s P/E ratio is 22.2.

Menicon Co., Ltd.

JPX · 7780
¥1,641-4(-0.24%)Market closedJPX regular session 09:00–15:00 JST
Ask about Menicon Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Menicon Co., Ltd. trades at a P/E of 22.2 (fair value) with modest ROE of 6.7%.

Ask for details

Company Overview

Menicon Co., Ltd. is a prominent player in the global optical and healthcare industry, primarily known for its expertise in the production of contact lenses. As a comprehensive contact lens manufacturer, Menicon specializes in designing and developing a diverse range of products, from disposable soft contact lenses to rigid gas permeable options. The company's key purpose is to deliver high-quality vision solutions while emphasizing safety, comfort, and innovation. Menicon operates within a niche segment of the healthcare sector, extending its impact across various markets where vision correction and eye care are critical. It also engages in the development of related optical materials and solutions, thereby contributing to advancements in eye health technology. The company's offerings are crucial for individuals requiring vision correction and professionals in optometry and ophthalmology. Founded in Japan, Menicon has expanded its footprint globally, leveraging its research and development capabilities to adapt to market demands and regulatory standards. As a significant entity in the optical products market, Menicon plays a critical role in enhancing the quality of life for individuals worldwide through improved vision care.

CEOMr. Koji Kawaura
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees4,325

Company Statistics

FY 2025

Profile

¥124,598,960,598Market Cap
¥121,491,000,000Revenue
0.00Shares Out
4,325Employees

Margins

53.57%Gross
15.44%EBITDA
8.27%Operating
7.67%Pre-Tax
4.63%Net

Valuation

22.16P/E
1.45P/B
1.03EV/Sales
8.41EV/EBITDA
-35.16P/FCF

Growth (CAGR)

6.64%Rev 3Yr
7.53%Rev 5Yr
0.32%Op Inc 3Yr
7.40%Op Inc 5Yr
-4.62%Net Inc 3Yr
6.72%Net Inc 5Yr

Returns

3.06%ROA
6.70%ROE
5.46%ROIC

Financial Health

¥42,046,000,000Cash & Cash Equivalents
¥59,085,000,000Net Debt
117.39%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Menicon Co., Ltd. (ticker: 7780) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 4,325 employees. Market cap is $124.6B.

The current price is 1,641 with a P/E ratio of 22.16x and P/B of 1.45x.

ROE is 6.70% and operating margin is 8.27%. Annual revenue is $121.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Menicon Co., Ltd. (7780) Stock Forecast 2026 ¥1,641 — Price, Financials & Analyst Targets | Alpha Lenz